Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Trojsi, Francesca ^a   Caiazzo, Giuseppina ^a   Corbo, Daniele ^b   Piccirillo, Giovanni ^a   Cristillo, Viviana ^a   Femiano, Cinzia ^a   Ferrantino, Teresa ^a   Cirillo, Mario ^a   Monsurrò, Maria Rosaria ^a   Esposito, Fabrizio ^a,c   Tedeschi, Gioacchino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ATROPHY; BRAIN STEM; CINGULATE GYRUS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUNEUS; DEGENERATIVE DISEASE; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; GLIOSIS; GRAY MATTER; HUMAN; INFERIOR FRONTAL GYRUS; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; NEUROIMAGING; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PYRAMIDAL TRACT; QUADRIPLEGIA; RIGHT HANDEDNESS; VOXEL BASED MORPHOMETRY; WHITE MATTER; AGED; ATROPHY; BRAIN; CASE CONTROL STUDY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84925584579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119045     Document Type: Article

References (76)

1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011; 377: 942-955. doi: 10.1016/S0140-6736(10)61156-7 PMID: 21296405
2. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008; 65: 636-641. doi: 10.1001/archneur.65.5.636 PMID: 18474740
3. Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009; 66: 180-189. doi: 10. 1001/archneurol.2008.558 PMID: 19204154
4. Kassubek J, Ludolph AC, Müller HP. Neuroimaging of motor neuron diseases. Ther Adv Neurol Disord. 2012; 5: 119-127. doi: 10.1177/1756285612437562 PMID: 22435076
5. Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al. Voxel based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007; 28: 1430-1438. PMID: 17370339
6. Agosta F, Valsasina P, Riva N, Copetti M, Messina MJ, Prelle A, et al. The cortical signature of amyotrophic lateral sclerosis. PLoS One 2012; 7: E42816. doi: 10.1371/journal.pone.0042816 PMID: 22880116
7. Cirillo M, Esposito F, Tedeschi G, Caiazzo G, Sagnelli A, Piccirillo G, et al. Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol. 2012; 33: 1102-1108. doi: 10.3174/ajnr.A2918 PMID: 22300932
8. Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, Hornberger M. Grey and white matter changes across the amyotrophic lateral sclerosis/frontotemporal dementia continuum. PLoS One 2012; 7: E43993. doi: 10.1371/journal.pone.0043993 PMID: 22952843
9. Mioshi E, Lillo P, Yew B, Hsieh S, Savage S, Hodges JR, et al. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology 2013; 80: 1117-1123. doi: 10.1212/ WNL.0b013e31828869da PMID: 23427327
10. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005; 65: 586-590. PMID: 16116120
11. Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology 2005; 64: 1222-1226. PMID: 15824350
12. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007; 6: 994-1003. PMID: 17945153
13. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257-268. doi: 10.1016/j.neuron.2011.09.010 PMID: 21944779
14. Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012; 135: 784-793. doi: 10.1093/brain/awr366 PMID: 22366794
15. Ling SC, Polymenidou M, Cleveland DV. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013; 79: 416-438. doi: 10.1016/j.neuron.2013.07.033 PMID: 23931993
16. Thomas M, Alegre-Abarrategui J, Wade-Martins R. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 2012; 136: 1345-1360.
17. Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat Rev Neurol. 2013; 9:708-714. doi: 10.1038/ nrneurol.2013.221 PMID: 24217521
18. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009; 11: 909-913. doi: 10.1038/ ncb1901 PMID: 19503072
19. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012; 338: 949-953. doi: 10.1126/science.1227157 PMID: 23161999
20. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: Blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123: 1191-1201. doi: 10.1242/jcs.051672 PMID: 20356930
21. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread. Neurology 2009; 73: 805-811. doi: 10.1212/WNL.0b013e3181b6bbbd PMID: 19738176
22. Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007; 68: 1571-1575. PMID: 17485643
23. Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013; 74: 20-38. doi: 10.1002/ana.23937 PMID: 23686809
24. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010; 75:1645-1652. doi: 10.1212/ WNL.0b013e3181fb84d1 PMID: 21041787
25. Tsermentseli S, Leigh PN, Goldstein LH. The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction. Cortex 2012; 48: 166-182. doi: 10.1016/j.cortex.2011. 02.004 PMID: 21396632
26. Kassubek J, Müller HP, Del Tredici K, Brettschneider J, Pinkhardt EH, Lulé D, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014; 137: 1733-1740. doi: 10.1093/brain/awu090 PMID: 24736303
27. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. NeuroImage 2000; 11: 805-821. PMID: 10860804
28. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000; 97:11050-1155. PMID: 10984517
29. Mezzapesa DM, Ceccarelli A, Dicuonzo F, Carella A, De Caro MF, Lopez M, et al. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007; 28: 255-259. PMID: 17296989
30. Grossman M, Anderson C, Khan A, Avants B, Elman L, McCluskey L. Impaired action knowledge in amyotrophic lateral sclerosis. Neurology 2008; 71: 1396-1401. doi: 10.1212/01.wnl.0000319701. 50168.8c PMID: 18784377
31. Menke RA, Körner S, Filippini N, Douaud G, Knight S, Talbot K, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 2014; 137: 2546-2555. doi: 10.1093/brain/awu162 PMID: 24951638
32. Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, et al. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging 2014; 35: 240-246. doi: 10.1016/j. neurobiolaging.2013.07.020 PMID: 23992619
33. Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012; 135: 847-852. doi: 10.1093/brain/awr351 PMID: 22271664
34. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage 2006; 31: 1487-1505. PMID: 16624579
35. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-299. PMID: 11464847
36. Chiò A, Calvo A, Moglia C, Mazzini L, Mora G, PARALS study group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011; 82: 740-746. doi: 10.1136/jnnp.2010.235952 PMID: 21402743
37. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13-21. PMID: 10540002
38. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [(11)C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004; 15: 601-609. PMID: 15056468
39. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085. PMID: 16977673
40. Grace J, Stout JC, Malloy PF. Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment 1999; 6: 269-284. PMID: 10445964
41. Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, et al. Tract probability maps in stereotaxic spaces: analysis of white matter anatomy and tract-specific quantification. NeuroImage 2008; 39: 336-347. PMID: 17931890
42. Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M, Gollub RL, et al. Reproducibility of quantitative tractography methods applied to cerebral white matter. NeuroImage 2007; 36: 630-644. PMID: 17481925
43. Mazziotta J, Toga AW, Evans AC, Fox PT, Lancaster J, Zilles K, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc London B Biol Sci. 2001; 356: 1293-1322. PMID: 11545704
44. Mazziotta J, Toga AW, Evans AC, Fox PT, Lancaster J, Zilles K, et al. Four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc. 2001; 8: 401-430. PMID: 11522763
45. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127: 2657-2671. PMID: 15509623
46. Eisen A. Amyotrophic lateral sclerosis: Evolutionary and other perspectives. Muscle Nerve 2009; 40: 297-304. doi: 10.1002/mus.21404 PMID: 19609920
47. Rosenbohm A, Kassubek J, Weydt P, Marroquin N, Volk AE, Kubisch C, et al. Can lesions to the motor cortex induce amyotrophic lateral sclerosis? J Neurol. 2014; 261: 283-290. doi: 10.1007/s00415-013-7185-7 PMID: 24253481
48. Chao YP, Cho KH, Yeh CH, Chou KH, Chen JH, Lin CP. Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography. Hum Brain Mapp. 2009; 30: 3172-3187. doi: 10.1002/hbm.20739 PMID: 19241418
49. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970; 33: 338-357. PMID: 5431724
50. Kiernan JA, Hudson AJ. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 1991; 114: 843-853. PMID: 2043953
51. Prell T, Peschel T, Hartung V, Kaufmann J, Klauschies R, Bodammer N, et al. Diffusion tensor imaging patterns differ in bulbar and limb onset amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2013; 115: 1281-1287. doi: 10.1016/j.clineuro.2012.11.031 PMID: 23266262
52. Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, et al. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 2013; 84: 766-773. doi: 10.1136/jnnp-2012-302674 PMID: 23085933
53. Libon DJ, McMillan C, Avants B, Boller A, Morgan B, Burkholder L, et al. Deficits in concept formation in amyotrophic lateral sclerosis. Neuropsychology 2012; 26: 422-429. doi: 10.1037/a0028668 PMID: 22612577
54. Sarro L, Agosta F, Canu E, Riva N, Prelle A, Copetti M, et al. Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: a diffusion tensor tractography study. AJNR Am J Neuroradiol. 2011; 32: 1866-1872. doi: 10.3174/ajnr.A2658 PMID: 22016410
55. Pettit LD, Bastin ME, Smith C, Bak TH, Gillingwater TH, Abrahams S. Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain 2013; 136: 3290-3304. doi: 10.1093/brain/awt243 PMID: 24056536
56. Tsujimoto M, Senda J, Ishihara T, Niimi Y, Kawai Y, Atsuta N, et al. Behavioural changes in early ALS correlate with voxel based morphometry and diffusion tensor imaging. J Neurol Sci. 2011; 307: 34-40. doi: 10.1016/j.jns.2011.05.025 PMID: 21641004
57. Donaghy C, Thurtell MJ, Pioro EP, Gibson JM, Leigh RJ. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J Neurol Neurosurg Psychiatry 2011; 82: 110-116. doi: 10.1136/jnnp.2010.212407 PMID: 21097546
58. Sharma R, Hicks S, Berna CM, Kennard C, Talbot K, Turner MR. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol. 2011; 68: 857-861. doi: 10.1001/ archneurol.2011.130 PMID: 21747027
59. Beaufils E, Corcia P, de Toffol B, Praline J. Occurrence of eye movement disorders in motor neuron disease. Amyotroph Lateral Scler. 2012; 13: 84-86. doi: 10.3109/17482968.2011.580848 PMID: 22117133
60. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011; 122: 691-702. doi: 10.1007/s00401-011-0911-2 PMID: 22101323
61. Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 2014; 127: 347-357. doi: 10.1007/s00401-013-1232-4 PMID: 24356984
62. Fekete T, Zach N, Mujica-Parodi LR, Turner MR. Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis. PLoS One 2013; 8: E85190. doi: 10.1371/journal.pone.0085190 PMID: 24391997
63. Keil C, Prell T, Peschel T, Hartung V, Dengler R, Grosskreutz J. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci. 2012; 13: 141. doi: 10.1186/1471-2202-13-141 PMID: 23134591
64. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012; 135: 736-750. doi: 10.1093/brain/awr361 PMID: 22366791
65. Tessitore A, Esposito F, Monsurrò MR, Graziano S, Panza D, Russo A, et al. Subcortical motor plasticity in patients with sporadic ALS: an fMRI study. Brain Res Bull. 2006; 69: 489-494. PMID: 16647577
66. Cistaro A, Valentini MC, Chiò A, Nobili F, Calvo A, Moglia C, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 2012; 39: 251-259. doi: 10.1007/s00259-011-1979-6 PMID: 22089661
67. Simone IL, Tortelli R, Samarelli V, D'Errico E, Sardaro M, Difruscolo O, et al. Laser evoked potentials in amyotrophic lateral sclerosis. J Neurol Sci. 2010; 288: 106-111. doi: 10.1016/j.jns.2009.09.023 PMID: 19836030
68. Chiò A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012; 19: 551-555. doi: 10.1111/j.1468-1331. 2011.03540.x PMID: 21972798
69. Eisen A,Weber M. The motor cortex and amyotrophiclateral sclerosis. Muscle Nerve 2001; 24: 564-573. PMID: 11268031
70. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol. 2011; 122: 657-671. doi: 10.1007/s00401-011-0913-0 PMID: 22105541
71. Verstraete E, Veldink JH, Hendrikse J, Schelhaas HJ, van den Heuvel MP, van den Berg LH. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012; 83: 383-388. doi: 10.1136/jnnp-2011-300909 PMID: 21965521
72. d'Ambrosio A, Gallo A, Trojsi F, Corbo D, Esposito F, Cirillo M, et al. Frontotemporal cortical thinning in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2014; 35: 304-310. doi: 10.3174/ajnr.A3753 PMID: 24113470
73. Kwan JY, Meoded A, Danielian LE, Wu T, Floeter MK. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. Neuroimage Clin. 2012; 2: 151-160. doi: 10.1016/j.nicl.2012.12.003 PMID: 24179768
74. Zhang J, Yin X, Zhao L, Evans AC, Song L, Xie B, et al. Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis. J Neurol. 2014; 261: 412-421. doi: 10.1007/ s00415-013-7215-5 PMID: 24452838
75. Gordon PH, Cheng B, Salachas F, Pradat PF, Bruneteau G, Corcia P, et al. Progression in ALS is not linear but is curvilinear. J Neurol. 2010; 257: 1713-1717. doi: 10.1007/s00415-010-5609-1 PMID: 20532545
76. Senda J, Kato S, Kaga T, Ito M, Atsuta N, Nakamura T, et al. Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler. 2011; 12: 59-69. doi: 10.3109/17482968.2010.517850 PMID: 21271792